Patients with shorter (≤28) CAG repeats in the NCOA3 gene were also shown to have a higher risk of disease progression (HR = 1.28, 95% CI = 1.01–1.66, P = 0.05 in a multivariate analysis for overall survival) after initial cytoreductive surgery for ovarian cancer [103]. This evidence concerns the gene NCOA3 and ovarian carcinoma.